Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-393-4 | CAS number: 54914-37-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The skin sensitization properties of the test substance were tested in the Albino Guinea Pig (Maximisation Test) according to OECD 406 in compliance with Good Laboratory Practice regulations (Notox B.V., 2000). The test substance was administered at a concentration of 0,5 % intradermally (in corn oil) and 20 % epidermally to 20 female guinea pigs. Sensitisation was observed in all animals in the challenge phase using a challenge concentration of 10 % test substance.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000-09-25 to 2000-11-02
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- (1992)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- (1996)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A skin sensitization test according to OECD 406 has already excisted since 2000 and is sufficient for evaluation of the skin sensitisation potential of the test substance.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- - Strain: Dunkin Hartley (SPF quality)
- Source: Charles River Deutschland, Kisslegg (Germany)
- Age: approx. 5 weeks
- Weight at study initiation: 412 +/- 23 g
- Controls: 10 females (422 +/- 19 g); treatment: vehicle - Route:
- other: see details below
- Vehicle:
- corn oil
- Concentration / amount:
- 1st application: Induction 0.5 % intracutaneous
2nd application: Induction 20 % occlusive epicutaneous
3rd application: Challenge 10 % occlusive epicutaneous - Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 1st application: Induction 0.5 % intracutaneous
2nd application: Induction 20 % occlusive epicutaneous
3rd application: Challenge 10 % occlusive epicutaneous - No. of animals per dose:
- 20
- Details on study design:
- ADMINISTRATION/EXPOSURE
- Preparation of test substance for induction: Within 4 hours prior to treatment, homogeneous preparation with vehicle
- Induction schedule:
Day 1: Injections
Day 3: Assessment for dermal irritation
Day 8: 48 hours occlusive patch with 0.5 ml of 20 % test substance on clipped injection sites (control animals: vehicle)
Day 10: Removal of patch and residual test substance, assessment for dermal irritation
- Injection details: 0.1 ml each at 6 positions in clipped scapular region:
2 x Freund's Complete Adjuvant (FCA) / water for injection (50:50)
2 x test substance 0.5 % in vehicle
2 x test substance 1.0 % in vehicle / FCA (50:50)
pairwise administration of each solution / suspension, symmetrical to midline and from cranial to caudal
controls: vehicle instead of test substance
- Challenge schedule:
Day 22: Two 24 hours occlusive patches (each 0.15 ml) with
(a) 10 % test substance and
(b) vehicle alone on one clipped flank
Day 23: Removal of patches and residual test substance
Days 24 and 25: Assessment for challenge reaction 24 and 48 hours after patch removal
- Rechallenge: no - Challenge controls:
- 10
- Positive control substance(s):
- yes
- Remarks:
- : alpha-hexylcinnamic aldehyde (tech. 85 %) (not more than 6 months previously)
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- Eschar formation and/or scabs were seen in the majority of the treated skin sites among the experimental animals
- Conclusions:
- The skin reactions observed in response to a 10% test substance concentration in all experimental animals in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals.
These results indicate a sensitisation rate of 100 per cent. - Executive summary:
The substance concentrations selected for the main study were based on the results of a preliminary study. In the main study, twenty experimental animals were intradermally injected with a 0,5% concentration and epidermally exposed to a 20% concentration. Ten control animals were similarly treated, but with vehicle alone (corn oil). Two weeks after the epidermal application all animals were challenged with a 10% test substance concentration and the vehicle. In the challenge phase, skin reactions varying between grades 1 and 3 were observed in all experimental animals in response to the 10% test substance concentration. No skin reactions were evident in the control animals. Eschar formation and/or scabs were seen in the majority of the treated skin sites among the experimental animals.
The skin reactions observed in response to a 10% test substance concentration in all experimental animals in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals. These results indicate a sensitisation rate of 100 per cent. Therefore, the test substance may cause an allergic skin reaction.
Reference
RESULTS OF PILOT STUDY:
A) Intracutaneous: Erythema at > 0.1 %; necrosis at > 0.5 %
B) Epicutaneous: At 24 hours reading erythema of grade 2 at 20 % and 50 %, necrosis and edema at 100 %. More serious findings in 50 % animals at 48 hours reading.
RESULTS OF TEST
- Sensitization reaction:
Skin reactions of grades 1-3 in 20/20 animals both 24 and 48 hours after removal of challenge patch. Additionally eschar formation and/or scabs in most animals at 48 hours reading. No skin reactions were evident in the control animals.
- Clinical signs: No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study.
- Other: Mean body weight gain 145 g in test group, 129 g in control group = same range
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
The skin sensitization properties of the test substance were tested in the Albino Guinea Pig (Maximisation Test) according to OECD 406 in compliance with Good Laboratory Practice regulations (Notox B.V., 2000). The test substance was administered at a concentration of 0,5 % intradermally (in corn oil) and 20 % epidermally to 20 female guinea pigs. Sensitisation was observed in all animals in the challenge phase using a challenge concentration of 10 % test substance.
The test substance is skin sensitizing in the Albino Guinea Pig (Maximisation Test) (Notox Project 303738, 2000)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The results of the skin sensitizing study in the Albino Guinea Pig (Maximisation Test) (Notox Project 303738, 2000) for
the test substance indicate a sensitisation rate of 100% in the experiment under the conditions employed and may cause an allergic skin reaction. It must therefore be classified according to the criteria of EC Directive 67/548/EEC and EC Regulation 1272/2008 as Skin Sens. 1A.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
